MDxHealth reported a gross margin of 65.75% and a net margin of -42.38% for the quarter ended Jun 2026. These financial ratios cover 21 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2020 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||
| Gross Margin | 46.62% | 46.56% | 46.57% | 55.79% | 56.04% | 59.29% | 59.66% | 64.87% | 65.32% | 60.82% | 59.96% | 61.22% | 62.72% | 63.82% | 67.88% | 65.04% | 63.25% | 60.67% | 65.75% | ||
| EBT Margin | -138.69% | -135.44% | 296,976.15% | -122.21% | -95.49% | -79.65% | -63.46% | -51.91% | -55.26% | -42.91% | -52.02% | -46.55% | -27.46% | -37.35% | -36.79% | -31.76% | -35.54% | -32.38% | -34.83% | ||
| EBIT Margin | -130.14% | -128.59% | -128.59% | -106.96% | -69.41% | -59.30% | -105.90% | -23.57% | -32.51% | -33.30% | -33.48% | -26.13% | -18.63% | -18.89% | -13.83% | -11.68% | -17.81% | -26.67% | -18.74% | ||
| EBITDA Margin | -130.14% | -128.59% | -128.59% | -106.96% | -69.41% | -59.30% | -105.90% | -23.57% | -22.53% | -22.87% | -22.06% | -16.59% | -5.57% | -5.48% | 2.38% | 1.25% | -7.15% | -15.84% | -8.43% | ||
| Operating Margin | -130.14% | -128.59% | -128.59% | -106.96% | -69.41% | -59.30% | -105.90% | -23.57% | -32.51% | -33.30% | -33.48% | -26.13% | -18.63% | -18.89% | -13.83% | -11.68% | -17.81% | -26.67% | -18.74% | ||
| Net Margin | -138.69% | -135.44% | -297,264.02% | -121.05% | -96.49% | -63.46% | -51.91% | -52.02% | -47.99% | 37.91% | -36.88% | -31.39% | -30.22% | 32.38% | -42.38% | ||||||
| FCF Margin | -92.43% | -132.35% | 99.87% | -42.77% | -16.20% | -23.58% | -17.58% | -23.20% | -8.88% | -7.54% | -1.87% | -4.13% | -21.35% | ||||||||
| Efficiency | |||||||||||||||||||||
| Inventory AverageInventory Avg. | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 2.77B | 2.77B | 0.01B | 0.01B | 0.01B | |||||
| Assets AverageAssets Avg. | 0.13B | 0.10B | 0.11B | 0.15B | 0.14B | 0.11B | 0.10B | 0.13B | 0.14B | 0.13B | 0.14B | 0.09B | 0.08B | 0.15B | 0.15B | 0.15B | |||||
| Invested CapitalInvested Cap. | 0.00B | 0.00B | 0.00B | 0.11B | 0.02B | 0.00B | 0.00B | 0.02B | 0.03B | 0.02B | 0.03B | 27.72B | 0.03B | 0.15B | 0.02B | 0.02B | |||||
| Asset Utilization RatioAsset Util. | 0.13 | 0.24 | 0.29 | 0.38 | 0.46 | 0.64 | 0.73 | 0.64 | 0.59 | 0.69 | 0.68 | 1.34 | 2.23 | 1.17 | 1.17 | 1.11 | |||||
| Leverage & Solvency | |||||||||||||||||||||
| Interest Coverage RatioInterest Cover | 15.21 | 18.78 | -3.12 | 7.01 | 2.66 | 0.83 | 1.69 | 0.89 | 0.54 | 1.00 | 0.82 | 0.84 | |||||||||
| Debt Ratio | 0.01 | 0.02 | 0.02 | 0.03 | 0.17 | 0.02 | 0.02 | 0.19 | 0.16 | 0.17 | 0.16 | 0.00B | 0.21 | 0.72 | 0.12 | 0.14 | |||||
| Times Interest Earned | 15.21 | 18.78 | -3.12 | 7.01 | 2.66 | 0.83 | 1.69 | 0.89 | 0.54 | 1.00 | 0.82 | 0.84 | |||||||||
| Valuation | |||||||||||||||||||||
| Enterprise Value | -0.04B | -0.04B | -0.03B | -0.04B | -0.04B | -0.03B | -0.02B | -0.02B | -0.05B | -0.03B | -0.07B | -0.84B | -0.03B | -0.03B | -0.04B | -0.02B | |||||
| Return Ratios | |||||||||||||||||||||
| Return on SalesROS | -0.01% | -0.01% | 29.70% | -0.01% | -0.01% | -5.55% | -0.01% | -0.01% | 0.00% | 0.00% | -0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||
| Return on Capital EmployedROCE | -18.02% | -23.63% | -44.94% | -33.22% | -38.40% | -41.93% | -30.62% | -26.80% | -24.18% | -23.73% | 0.04% | -94.23% | -24.82% | -24.75% | -24.58% | ||||||
| Return on Invested CapitalROIC | -0.05% | 0.00% | 0.00% | -0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |||||||||||
| Return on AssetsROA | -1.45% | -1.81% | -1.58% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -0.01% | 0.00% | 0.00% | 0.00% |